| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.32 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |